Presenting at CMSC 2022, researchers analyzed the development of whole-brain atrophy and white matter lesions in patients with CDMS.
Presenting at CMSC 2022, researchers evaluated the decline in the anti-JCV antibody index in patients with MS through 2 years of ocrelizumab treatment.
In a phase 3 trial, researchers assessed the safety and efficacy of ultra-high dose methylcobalamin in slowing functional decline in patients with ALS.
Using a comprehensive neuropsychological battery and other measures of motor functioning, researchers examined the relationship between cognitive and clinical factors in adult patients with type 3 SMA.
Researchers evaluated the safety and efficacy of neuromuscular electric stimulation therapy in the reduction of knee osteoarthritis-related pain, stiffness, and function.
Researchers assessed patients who developed a new-onset neuromuscular disorder the first 6 weeks after receiving either the first or second dose of the COVID-19 vaccine.
Researchers sought to characterize the neuropsychological and lesion traits of patients with stroke who self-reported clinically significant apathy in 1 or more subdomains of the Dimensional Apathy Scale.
Researchers sought to assess whether serum urate possesses a neuroprotective effect against the risk for Parkinson disease in patients with gout.
Cognitive issues are often reported by people with hypoparathyroidism, but there has been limited study data to link the two. Researchers analyzed the potential association.
Numerous people on thyroid replacement therapy for hypothyroidism describe symptom such as persistent ‘brain fog.’ Researchers aimed to better understand what other issues ‘brain fog’ may be related to.
Advanced glycation end products (AGE) are a factor in diabetic end-organ damage and several diabetic complications. Investigators studied whether measuring AGE with skin autofluorescence (SAF) could predict diabetic complications.
A team of investigators from McMaster University assessed the effect of aging on skeletal muscle function in individuals with and without type 1 diabetes.
